We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$36.6M
Cap. Flow
+$56.2M
Cap. Flow %
29.55%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
3
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
NOTV
Inotiv
NOTV
+$42.6M
2
NTP
Nam Tai Property Inc.
NTP
+$15.6M
3
LFCR icon
Lifecore Biomedical
LFCR
+$2.69M
4
CO
Global Cord Blood Corporation
CO
+$4.25K

Top Sells

Rank Stock Value
1
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$3.97M
2
MTBL
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
+$506K
3
CCEL icon
Cryo-Cell International
CCEL
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 76.31%
2 Real Estate 19.96%
3 Consumer Discretionary 3.73%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDMO
1
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$64.4M 33.9%
2,208,313
-138,648
-6% -$3.97M
NOTV
2
DELISTED
Inotiv
NOTV
$53.7M 28.22%
1,275,379
+951,250
+293% +$42.6M
NTP
3
DELISTED
Nam Tai Property Inc.
NTP
$37.9M 19.96%
6,673,362
+781,985
+13% +$15.6M
LFCR icon
4
Lifecore Biomedical
LFCR
$166M
$21.4M 11.24%
1,925,311
+276,791
+17% +$2.69M
XPEL icon
5
XPEL
XPEL
$1.22B
$7.09M 3.73%
103,860
– –
CCEL icon
6
Cryo-Cell International
CCEL
$27.6M
$5.6M 2.95%
482,931
-13,572
-3% -$169K
CO
7
DELISTED
Global Cord Blood Corporation
CO
$4K ﹤0.01%
+1,000
New +$4.25K
MTBL
8
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
– –
-363,840
Closed -$506K

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, ISZO Capital Management held 8 positions worth $190M, down 16% from $227M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management deployed $56.2M of net new capital in Q4 2021, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Global Cord Blood Corporation: 1,000 shares worth $4K.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 36% a quarter earlier, followed by Real Estate and Consumer Discretionary.

On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $3.97M trimmed.

  • ISZO Capital Management's largest Q4 2021 buy was Global Cord Blood Corporation: 1,000 shares worth $4K.
  • ISZO Capital Management added most to Inotiv in Q4 2021, an estimated $42.6M increase.
  • ISZO Capital Management's biggest Q4 2021 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $3.97M.
  • ISZO Capital Management fully exited Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares) in Q4 2021, selling an estimated $506K.
  • ISZO Capital Management's ten largest holdings make up 100% of its $190M portfolio in Q4 2021.
  • ISZO Capital Management opened 1 new position and closed 1 in Q4 2021.
  • ISZO Capital Management's portfolio value fell 16% quarter-over-quarter to $190M.

Based on ISZO Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.